Quantamental Technologies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Quantamental Technologies’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,332	Closed	-$273K	–	687
2023 Q1	$273K	Buy	+7,332	New	+$330K	0.15%	261
2022 Q3	–	Sell	-7,101	Closed	-$477K	–	696
2022 Q2	$477K	Buy	+7,101	New	+$452K	0.22%	173
2022 Q1	–	Sell	-1,488	Closed	-$218K	–	580
2021 Q4	$218K	Buy	+1,488	New	+$231K	0.11%	317
2020 Q3	–	Sell	-2,558	Closed	-$292K	–	393
2020 Q2	$292K	Buy	+2,558	New	+$248K	0.2%	171
2019 Q4	–	Sell	-94	Closed	-$7K	–	1448
2019 Q3	$7K	Sell	94 -483	-84%	-$45.3K	﹤0.01%	1361
2019 Q2	$59K	Buy	+577	New	+$44.9K	0.02%	846

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Quantamental Technologies's MRTX Position: Q2 2023 in Review

Quantamental Technologies sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 7,332 shares — an estimated $273K sold.

Quantamental Technologies first reported a position in MRTX in Q2 2019 and held it in 6 quarters. The position peaked at $477K in Q2 2022. 207 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

Quantamental Technologies reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Quantamental Technologies sold 7,332 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $273K.
Quantamental Technologies first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
Quantamental Technologies's Mirati Therapeutics, Inc. Common Stock position peaked at $477K in Q2 2022.
207 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.